Changshan Pharmaceutical said on an interactive platform on October 21 that the company currently does not have GLP-1 dual-target and three-target pipelines.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.